Arcturus Therapeutics Holdings Inc (ARCT)

Cost of Revenue

$0.00

Quarterly · Period ending: · USD

ARCT logo

ARCT Cost of Revenue

Latest reported$0.00
ARCT Quarterly Cost of Revenue ($0.00 → $0.00)
High-resolution chart · PNG

ARCT cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arcturus Therapeutics Holdings Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
0
658,000
0
3,342,000
0
0
0
0
0
0
0
0
3,741,000
51,768,000
26,981,000
37,688,000
38,189,000
44,893,000
30,733,000
45,398,000
45,679,000
50,050,000
22,386,000
0
0
0
11,994,000
7,053,000
7,269,000
7,324,000
4,847,000
3,969,000
4,225,000
3,941,000
4,353,000
3,563,000
3,769,000
4,001,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.